Logo image of AZPN

ASPEN TECHNOLOGY INC (AZPN) Stock Fundamental Analysis

NASDAQ:AZPN - US29109X1063 - Common Stock

264.33 USD
+0.03 (+0.01%)
Last: 3/11/2025, 8:00:02 PM
264.6 USD
+0.27 (+0.1%)
After Hours: 3/11/2025, 8:00:02 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to AZPN. AZPN was compared to 280 industry peers in the Software industry. While AZPN has a great health rating, there are worries on its profitability. AZPN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year AZPN was profitable.
In the past year AZPN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: AZPN reported negative net income in multiple years.
In the past 5 years AZPN always reported a positive cash flow from operatings.
AZPN Yearly Net Income VS EBIT VS OCF VS FCFAZPN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

AZPN has a Return On Assets of -0.07%. This is in the better half of the industry: AZPN outperforms 60.85% of its industry peers.
The Return On Equity of AZPN (-0.08%) is better than 62.28% of its industry peers.
Industry RankSector Rank
ROA -0.07%
ROE -0.08%
ROIC N/A
ROA(3y)-0.15%
ROA(5y)8.06%
ROE(3y)-0.17%
ROE(5y)17.74%
ROIC(3y)N/A
ROIC(5y)N/A
AZPN Yearly ROA, ROE, ROICAZPN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600

1.3 Margins

AZPN has a Gross Margin of 66.07%. This is comparable to the rest of the industry: AZPN outperforms 48.40% of its industry peers.
AZPN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for AZPN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.29%
GM growth 5Y-6.06%
AZPN Yearly Profit, Operating, Gross MarginsAZPN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

9

2. Health

2.1 Basic Checks

AZPN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AZPN has been reduced compared to 1 year ago.
The number of shares outstanding for AZPN has been reduced compared to 5 years ago.
There is no outstanding debt for AZPN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AZPN Yearly Shares OutstandingAZPN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
AZPN Yearly Total Debt VS Total AssetsAZPN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.2 Solvency

An Altman-Z score of 8.76 indicates that AZPN is not in any danger for bankruptcy at the moment.
The Altman-Z score of AZPN (8.76) is better than 82.21% of its industry peers.
AZPN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.76
ROIC/WACCN/A
WACC10.78%
AZPN Yearly LT Debt VS Equity VS FCFAZPN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 3.33 indicates that AZPN has no problem at all paying its short term obligations.
The Current ratio of AZPN (3.33) is better than 76.87% of its industry peers.
AZPN has a Quick Ratio of 3.33. This indicates that AZPN is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 3.33, AZPN is doing good in the industry, outperforming 76.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.33
Quick Ratio 3.33
AZPN Yearly Current Assets VS Current LiabilitesAZPN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.03% over the past year.
AZPN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.94% yearly.
AZPN shows a small growth in Revenue. In the last year, the Revenue has grown by 7.98%.
The Revenue has been growing by 13.57% on average over the past years. This is quite good.
EPS 1Y (TTM)22.03%
EPS 3Y8.27%
EPS 5Y9.94%
EPS Q2Q%50.36%
Revenue 1Y (TTM)7.98%
Revenue growth 3Y16.7%
Revenue growth 5Y13.57%
Sales Q2Q%18.04%

3.2 Future

AZPN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.03% yearly.
AZPN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.75% yearly.
EPS Next Y17.25%
EPS Next 2Y11.33%
EPS Next 3Y10.88%
EPS Next 5Y7.03%
Revenue Next Year7.88%
Revenue Next 2Y7.71%
Revenue Next 3Y7.91%
Revenue Next 5Y8.75%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AZPN Yearly Revenue VS EstimatesAZPN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
AZPN Yearly EPS VS EstimatesAZPN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 37.87 indicates a quite expensive valuation of AZPN.
Compared to the rest of the industry, the Price/Earnings ratio of AZPN indicates a somewhat cheap valuation: AZPN is cheaper than 61.57% of the companies listed in the same industry.
AZPN is valuated rather expensively when we compare the Price/Earnings ratio to 27.07, which is the current average of the S&P500 Index.
AZPN is valuated quite expensively with a Price/Forward Earnings ratio of 32.31.
Based on the Price/Forward Earnings ratio, AZPN is valued a bit cheaper than the industry average as 64.77% of the companies are valued more expensively.
AZPN's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.59.
Industry RankSector Rank
PE 37.87
Fwd PE 32.31
AZPN Price Earnings VS Forward Price EarningsAZPN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AZPN is valued a bit cheaper than the industry average as 68.68% of the companies are valued more expensively.
AZPN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 54.42
EV/EBITDA 40.9
AZPN Per share dataAZPN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.2
PEG (5Y)3.81
EPS Next 2Y11.33%
EPS Next 3Y10.88%

0

5. Dividend

5.1 Amount

No dividends for AZPN!.
Industry RankSector Rank
Dividend Yield N/A

ASPEN TECHNOLOGY INC

NASDAQ:AZPN (3/11/2025, 8:00:02 PM)

After market: 264.6 +0.27 (+0.1%)

264.33

+0.03 (+0.01%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-04 2025-02-04/amc
Earnings (Next)N/A N/A
Inst Owners46.66%
Inst Owner Change-10.03%
Ins Owners0.05%
Ins Owner Change-58.04%
Market Cap16.73B
Analysts73.75
Price Target272.83 (3.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.49
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-19.3%
Min EPS beat(2)-46.89%
Max EPS beat(2)8.29%
EPS beat(4)3
Avg EPS beat(4)-3.07%
Min EPS beat(4)-46.89%
Max EPS beat(4)14.53%
EPS beat(8)3
Avg EPS beat(8)-11%
EPS beat(12)5
Avg EPS beat(12)-6.65%
EPS beat(16)7
Avg EPS beat(16)-4.89%
Revenue beat(2)1
Avg Revenue beat(2)-9.99%
Min Revenue beat(2)-20.92%
Max Revenue beat(2)0.94%
Revenue beat(4)3
Avg Revenue beat(4)-2.09%
Min Revenue beat(4)-20.92%
Max Revenue beat(4)6.27%
Revenue beat(8)3
Avg Revenue beat(8)-5.74%
Revenue beat(12)4
Avg Revenue beat(12)-13.98%
Revenue beat(16)4
Avg Revenue beat(16)-17.24%
PT rev (1m)3.03%
PT rev (3m)9.8%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.73%
EPS NY rev (1m)0%
EPS NY rev (3m)1.49%
Revenue NQ rev (1m)1.62%
Revenue NQ rev (3m)4.06%
Revenue NY rev (1m)0.33%
Revenue NY rev (3m)0.25%
Valuation
Industry RankSector Rank
PE 37.87
Fwd PE 32.31
P/S 14.84
P/FCF 54.42
P/OCF 51.21
P/B 1.31
P/tB 36.33
EV/EBITDA 40.9
EPS(TTM)6.98
EY2.64%
EPS(NY)8.18
Fwd EY3.09%
FCF(TTM)4.86
FCFY1.84%
OCF(TTM)5.16
OCFY1.95%
SpS17.81
BVpS201.82
TBVpS7.28
PEG (NY)2.2
PEG (5Y)3.81
Profitability
Industry RankSector Rank
ROA -0.07%
ROE -0.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.07%
FCFM 27.27%
ROA(3y)-0.15%
ROA(5y)8.06%
ROE(3y)-0.17%
ROE(5y)17.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.29%
GM growth 5Y-6.06%
F-Score8
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 3.91%
Cap/Sales 1.71%
Interest Coverage N/A
Cash Conversion 80.75%
Profit Quality N/A
Current Ratio 3.33
Quick Ratio 3.33
Altman-Z 8.76
F-Score8
WACC10.78%
ROIC/WACCN/A
Cap/Depr(3y)2.54%
Cap/Depr(5y)9.1%
Cap/Sales(3y)1%
Cap/Sales(5y)0.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.03%
EPS 3Y8.27%
EPS 5Y9.94%
EPS Q2Q%50.36%
EPS Next Y17.25%
EPS Next 2Y11.33%
EPS Next 3Y10.88%
EPS Next 5Y7.03%
Revenue 1Y (TTM)7.98%
Revenue growth 3Y16.7%
Revenue growth 5Y13.57%
Sales Q2Q%18.04%
Revenue Next Year7.88%
Revenue Next 2Y7.71%
Revenue Next 3Y7.91%
Revenue Next 5Y8.75%
EBIT growth 1Y51.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year21.32%
EBIT Next 3Y18.97%
EBIT Next 5Y7.32%
FCF growth 1Y194.26%
FCF growth 3Y5.65%
FCF growth 5Y6.4%
OCF growth 1Y203.73%
OCF growth 3Y7.17%
OCF growth 5Y7.36%